the vaccine – Page 138 – Communicable Diseases Research

Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2

Research

Published on 2020-10-292022-10-28
Journal: Virology Journal [Category] COVID-19, MERS, SARS,

Systems Biology Approaches for Therapeutics Development Against COVID-19

COVID-19에 대한 치료제 개발을 위한 시스템 생물학 접근법

Review

Published on 2020-10-282022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 치료제,

Polio in Afghanistan: The Current Situation amid COVID-19

아프가니스탄의 폴리오: COVID-19 속 현재 상황

Perspective Piece

Published on 2020-10-272022-10-28
Journal: The American Journal of Tropical Medicine and Hygi [Category] Coronavirus, MERS, SARS, 폴리오,

[키워드] Afghanistan children country COVID-19 current disease Endemic illiteracy inaccessible include initial lockdown New polio reduce refusal Region situation Spread the vaccine vaccination viral disease
[DOI] 10.4269/ajtmh.20-1010 PMC 바로가기 [Article Type] Perspective Piece

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

COVID-19에 대한 타고난 면역 반응을 개선하기 위해 브라질에서 의료 종사자의 BCG 재접종: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-10-262022-08-13
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] accompany activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Antibiotics antiviral immune response approved assigned Autoimmune Autoimmune diseases Bacillus BCG BCG revaccination BCG vaccination bcg vaccine blinded Blinding block blocks both groups Brazil Breastfeeding carried CFU Characteristics Chemotherapy childhood city clinical trial Committee Comorbidities Comorbidity confirmation Contact contact with control group Coronavirus-2 COVID-19 COVID-19 patient COVID-19 severity COVID-19 symptoms COVID-19 test cross-protection determined by diagnosed direct contact disease disease severity Diseases dissemination dose doses Effectiveness element elicited eligibility criteria Fever health worker health workers healthcare providers HIV hospital Hypothesis ICU identification number IgG and IgM IgM and IgG IgM test immunosuppressive IMPROVE in both group incidence incidence of COVID-19 Inclusion inclusion criteria India induce Infection infections information innate immune response investigator Laboratory lateral flow less macrophages medication meet memory monocyte Monocytes Mortality naso-oropharyngeal swab neutrophil Neutrophils NK NK cell number Nurses objective Open-label outcome outcomes pandemic parallel-group participant physiotherapists platform presenting Prevent Primary outcome Primary outcomes professional protocol randomisation randomised randomised controlled trial randomization Randomized receive recruit recruitment reduce Registered registration number researcher researchers respiratory revaccination right arm RT-PCR Sample size SARS-CoV-2 scar sealed Secondary objective Secondary objectives secondary outcome severe acute respiratory syndrome Coronavirus severity solid tumour specimen statistical analyses status steroid Study protocol Symptom symptomatic infection the disease the vaccine Trial Trial registration Tuberculosis two groups vaccination Vaccine virus virus infection virus infections was performed website WHO
[DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter

Survey data for COVID-19 vaccine preference analysis in the United Arab Emirates

Data Article

Published on 2020-10-222022-10-31
Journal: Sensors (Basel, Switzerland) [Category] COVID-19,

Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination

Research

Published on 2020-10-202022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS, SARS,

[키워드] 95% CI Adults adverse effect adverse effects age Analysis approval asked assigned attribute baseline black calculated center Characteristics China collected conducted Control coronavirus disease country COVID-19 COVID-19 vaccine decrease demographic characteristics drug effect size Efficacy Emergency use authorization evaluate evaluated Factor FDA FDA approval finding food Health care help hypothetical Importance incidence increase in increases in Latinx Level likelihood marginal mean measure median age National objective pandemic participant Participants Point preference President prevention Probability progressed public health Randomized Randomly receive receiving recruited reduction in Relevance Result setting Sex Side effect survey the vaccine vaccination Vaccine Vaccine hesitancy white women World Health Organization
[DOI] 10.1001/jamanetworkopen.2020.25594 PMC 바로가기 [Article Type] Research

Current Prevention of COVID-19: Natural Products and Herbal Medicine

Pharmacology

Published on 2020-10-162022-10-31
Journal: Frontiers in Pharmacology [Category] COVID-19,

[키워드] Acute respiratory infection agency approach approved caused clinical trials coronavirus Coronavirus disease 2019 COVID-19 current demonstrated economic loss Effectiveness Efficacy and safety effort globe Health Herbal herbal medicine inhibitory effect less Medicine natural natural product novel coronavirus disease pandemic prevention product Prophylactic public health question Regulatory released respiratory infectious disease SARS-CoV-2 SARS-CoV-2 transmission severe acute respiratory syndrome coronavirus 2 stability starting the vaccine Toxicity Treatment Vaccine vaccine candidate Vaccine development while
[DOI] 10.3389/fphar.2020.588508 PMC 바로가기 [Article Type] Pharmacology

Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial

이중 맹검, 무작위, 위약 대조 임상 3상 임상 시험을 통해 의료 전문가를 Sinovac에서 제조한 흡착된 COVID-19(불활성화) 백신으로 치료하는 효과와 안전성을 평가합니다. – PROFISCOV: 무작위 대조를 위한 연구 프로토콜의 구조화된 요약 재판

Letter

Published on 2020-10-152022-08-13
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] 95% confidence interval Active surveillance adjuvant Administered administration Adults adverse event adverse events Adverse reaction Adverse reactions age Aluminium aluminium hydroxide Analysis attack rate Beijing blind Blinding Brazil Breastfeeding calculated Care causal relationship China clinical clinical care clinically Committee completion confirmed case Consent consent form Contact contact with Control COVID-19 criterion database defined Diagnosis direct contact disease dissemination dose double-blind double-blind study Efficacy Efficacy and safety elderly element Endpoint evaluate exclusion criteria expected experimental intervention FDA form Frequency genders Health Health Organization hydroxide immunogenicity inactivated Inactivated Vaccines incidence include Inclusion information Informed intramuscular dose life limit Local monitoring multicenter nucleic acid number Nurse Nurses objective Occurrence Older outcome participant Participants Participation Patient phase Phase III Clinical Trial Placebo placebo-controlled clinical trial pregnant pregnant women primary efficacy endpoint produced product professional professionals protocol randomisation randomised randomised controlled trial randomization randomization list randomization system Randomized receive recruitment regimen registry responsible retained Safety Sample size SARS-CoV-2 nucleic acid SARS-CoV-2 virus schedule second vaccination separation Sinovac Sinovac Life Science Sinovac Life Sciences Sponsor status stratified Study protocol subjects symptomatic case symptomatic cases symptomatic individuals systemic adverse reaction systemic adverse reactions the vaccine threshold Trial Trial registration undergo vaccination Vaccine Virological voluntary website World Health Organization
[DOI] 10.1186/s13063-020-04775-4 PMC 바로가기 [Article Type] Letter

Susceptibility to misinformation about COVID-19 around the world

1001

Published on 2020-10-142022-10-28
Journal: Royal Society Open Science [Category] COVID-19,

Public preference for COVID‐19 vaccines in China: A discrete choice experiment

Original Research Paper

Published on 2020-10-062022-11-01
Journal: Health Expectations : An International Journal of Public Participation in Health Care and Health Policy [Category] COVID-19, MERS,